These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 18641513)

  • 1. Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray.
    Lebet T; Chiles R; Hsu AP; Mansfield ES; Warrington JA; Puck JM
    Genet Med; 2008 Aug; 10(8):575-85. PubMed ID: 18641513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.
    Bayer DK; Martinez CA; Sorte HS; Forbes LR; Demmler-Harrison GJ; Hanson IC; Pearson NM; Noroski LM; Zaki SR; Bellini WJ; Leduc MS; Yang Y; Eng CM; Patel A; Rodningen OK; Muzny DM; Gibbs RA; Campbell IM; Shaw CA; Baker MW; Zhang V; Lupski JR; Orange JS; Seeborg FO; Stray-Pedersen A
    Clin Exp Immunol; 2014 Dec; 178(3):459-69. PubMed ID: 25046553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis in primary immunodeficiency diseases: case studies.
    Hsu AP; Fleisher TA; Niemela JE
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):517-24. PubMed ID: 19841577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Henthorn PS; Candotti F; Isakov J; Whitwam T; Conley ME; Fischer RE; Rosenblatt HM; Small TN; Buckley RH
    Blood; 1997 Mar; 89(6):1968-77. PubMed ID: 9058718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.
    Stephan JL; Vlekova V; Le Deist F; Blanche S; Donadieu J; De Saint-Basile G; Durandy A; Griscelli C; Fischer A
    J Pediatr; 1993 Oct; 123(4):564-72. PubMed ID: 8410508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.
    Brown L; Xu-Bayford J; Allwood Z; Slatter M; Cant A; Davies EG; Veys P; Gennery AR; Gaspar HB
    Blood; 2011 Mar; 117(11):3243-6. PubMed ID: 21273302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
    Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
    J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency.
    Lipstein EA; Vorono S; Browning MF; Green NS; Kemper AR; Knapp AA; Prosser LA; Perrin JM
    Pediatrics; 2010 May; 125(5):e1226-35. PubMed ID: 20403930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
    Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
    JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell immunity to infection with dengue virus in humans.
    Weiskopf D; Sette A
    Front Immunol; 2014; 5():93. PubMed ID: 24639680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.
    Rothman AL
    Nat Rev Immunol; 2011 Jul; 11(8):532-43. PubMed ID: 21760609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a host process as an antiviral approach against dengue virus.
    Sayce AC; Miller JL; Zitzmann N
    Trends Microbiol; 2010 Jul; 18(7):323-30. PubMed ID: 20452219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.
    Griffith LM; Cowan MJ; Notarangelo LD; Puck JM; Buckley RH; Candotti F; Conley ME; Fleisher TA; Gaspar HB; Kohn DB; Ochs HD; O'Reilly RJ; Rizzo JD; Roifman CM; Small TN; Shearer WT;
    J Allergy Clin Immunol; 2009 Dec; 124(6):1152-60.e12. PubMed ID: 20004776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
    Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
    Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Synonymous Variant in IL7R Causes Preferential Expression of the Soluble Isoform.
    Mackeh R; El Bsat Y; Elmi A; Bibawi H; Karim MY; Hassan A; Lo B
    J Clin Immunol; 2024 Apr; 44(4):96. PubMed ID: 38587703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious and Oncogenic Mutations in the
    Campos LW; Pissinato LG; Yunes JA
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia.
    Puck JM
    Immunol Rev; 2019 Jan; 287(1):241-252. PubMed ID: 30565242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History and current status of newborn screening for severe combined immunodeficiency.
    Kwan A; Puck JM
    Semin Perinatol; 2015 Apr; 39(3):194-205. PubMed ID: 25937517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.
    Dvorak CC; Cowan MJ; Logan BR; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Shearer WT; O'Reilly RJ; Fleisher TA; Pai SY; Hanson IC; Pulsipher MA; Fuleihan R; Filipovich A; Goldman F; Kapoor N; Small T; Smith A; Chan KW; Cuvelier G; Heimall J; Knutsen A; Loechelt B; Moore T; Buckley RH
    J Clin Immunol; 2013 Oct; 33(7):1156-64. PubMed ID: 23818196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.